FDA will allow doctors to treat critically ill coronavirus patients with blood from survivors
(Photo: Doctors test hospital staff with flu-like symptoms for COVID-19 in triage tents at St. Barnabas Hospital in the Bronx borough of New York on March 24, 2020. By Misha Friedman)
COPENHAGEN, Mar 26
The Food and Drug Administration will allow doctors across the country in the United States to begin treating critically ill coronavirus patients with antibody-rich plasma extracted from the blood of those who’ve recovered under new emergency protocols approved on March 24, 2020.
Dr. Jeffrey Henderson, an associate professor of medicine and molecular microbiology at the Washington University School of Medicine, addressed that the approach definitely has merit. Even though it is not yet certain about the effectiveness of the method at the moment, he thinks it has a very good chance of working based on its track record with a number of other viruses.
Experts said that if the treatment is proven safe and effective it would likely work best if given to patients before symptoms become too severe. And past studies indicate that proactive infusions of convalescent plasma might also be effective in protecting front line health care workers from becoming seriously ill.
Read the entire article here.